Blue Trust’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28 Buy
+2
New +$16 ﹤0.01% 2490
2024
Q4
– Sell
-2,129
Closed -$712 – 2578
2024
Q3
$712 Buy
2,129
+2,013
+1,735% +$20.2K ﹤0.01% 2753
2024
Q2
$5.37K Buy
+116
New +$3.46K ﹤0.01% 2180
2024
Q1
– Sell
-91
Closed -$7K – 2318
2023
Q4
$7K Buy
+91
New +$5.57K ﹤0.01% 1701
2023
Q2
– Sell
-42
Closed -$3K – 2129
2023
Q1
$3K Buy
42
+20
+91% +$1.27K ﹤0.01% 1905
2022
Q4
$2K Buy
+22
New +$2.02K ﹤0.01% 1912

Other funds holding DNA

Blue Trust's DNA Position: Q3 2026 in Review

Blue Trust opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 2 shares worth $28. The stake represents ﹤0.01% of the portfolio and ranks #2490 among its holdings. This is a return to the name: Blue Trust previously reported a position in DNA as recently as Q3 2024.

Blue Trust first reported a position in DNA in Q4 2022 and has held it in 6 quarters since. The position peaked at $7K in Q4 2023. 132 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Blue Trust held 2 shares of Ginkgo Bioworks worth $28 as of Q3 2026.
  • Ginkgo Bioworks was a new Blue Trust position in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2490 holding.
  • Blue Trust first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 6 quarters since.
  • Blue Trust's Ginkgo Bioworks position peaked at $7K in Q4 2023.
  • 132 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.